Probiotics for Metabolism: Best Strains, Mechanisms & What the Research Actually Shows
A science-based guide to how gut bacteria influence fat storage, insulin sensitivity, and metabolic health
The connection between your gut and your metabolism is no longer speculative. Over the past decade, a growing body of peer-reviewed research has confirmed that the trillions of bacteria living in your digestive tract play a direct role in how your body processes calories, stores fat, regulates blood sugar, and responds to insulin. When that microbial community is diverse and well-balanced, metabolic processes run more efficiently. When it's disrupted — a state researchers call dysbiosis — the consequences extend well beyond digestion.
Probiotics, taken consistently at clinically meaningful doses, represent one of the most studied dietary strategies for supporting a healthy gut-metabolism axis. But not every strain does the same thing. The research on probiotics and metabolism is strain-specific, dose-dependent, and highly nuanced. This guide cuts through the noise to examine what peer-reviewed science actually says about specific probiotic strains, the mechanisms through which they support metabolic health, and how to select a formulation designed to deliver results.
For context on how your gut microbiome diversity connects to broader health outcomes, our article on the top probiotic strains for gut health provides a useful foundation before diving into metabolic specifics.
Key Takeaways
- Lactobacillus gasseri produced a significant decrease in visceral adipose tissue in a multicenter, double-blind, randomized, placebo-controlled trial — one of the most studied strains for abdominal fat specifically.[1]
- Bifidobacterium breve B-3 was shown to significantly reduce body fat mass and percent body fat compared to placebo in a 12-week randomized controlled trial in pre-obese adults.[2]
- Lactobacillus rhamnosus improves insulin sensitivity and reduces adiposity through enhancement of adiponectin production and activation of the AMPK metabolic pathway.[3]
- Short-chain fatty acids (SCFAs) — produced when probiotic strains ferment prebiotic fiber — are among the primary molecular messengers linking gut bacteria to systemic metabolic regulation, including GLP-1 stimulation and appetite signaling.[4]
- Bacillus coagulans supplementation significantly reduced fasting blood glucose, insulin, and HOMA-IR in a randomized clinical trial of patients with type 2 diabetes.[5]
- Multi-strain probiotic formulas consistently outperform single-strain supplements in metabolic trials, with synergistic strain combinations showing greater anti-adipogenic effects than any individual species alone.[6]
The Gut–Metabolism Connection: What the Science Shows
Groundbreaking research has established that gut microbiome composition is not simply a downstream consequence of metabolic health — it is an active upstream regulator of it. Studies comparing gut microbiota between lean and obese individuals consistently identify differences in microbial diversity, species ratios, and functional metabolite output that are difficult to explain through diet and lifestyle alone.
One of the most replicated observations in the field is an altered ratio of two dominant bacterial phyla — Firmicutes and Bacteroidetes — in people with obesity. Dysbiosis characterized by reduced bacterial diversity is consistently linked to elevated inflammatory markers, impaired glucose tolerance, and increased fat storage. When gut flora from obese rodents is transplanted into germ-free lean animals, the lean recipients gain body fat — a striking demonstration that microbiome composition can drive metabolic outcomes independent of caloric intake.[7]
This body of evidence has opened a new field of inquiry: can deliberately restoring or enriching specific bacterial populations through probiotic supplementation reverse or mitigate these metabolic effects? Increasingly, the answer from randomized controlled trials appears to be yes — but the quality of the evidence varies significantly by strain, dose, and population studied.
If you've noticed signs consistent with gut-related metabolic disruption — including difficulty managing weight, blood sugar irregularities, or chronic fatigue — it's worth understanding the signs your gut may need probiotic support before choosing a supplement.
The Firmicutes/Bacteroidetes Ratio and Metabolic Health
Firmicutes are highly efficient at extracting energy from food — an evolutionary advantage in environments of food scarcity that becomes a liability in calorie-dense modern diets. Obese individuals tend to have a higher proportion of Firmicutes relative to Bacteroidetes compared to lean counterparts. Probiotic supplementation with Lactobacillus and Bifidobacterium strains has been shown to modulate this ratio and reduce metabolic endotoxemia — the condition where gut bacterial byproducts enter circulation and trigger chronic low-grade inflammation, a key driver of insulin resistance.[7]
How Probiotics Influence Metabolic Function
Understanding why probiotics can influence metabolism requires looking at several interconnected biological pathways. The gut is now recognized as the body's largest endocrine organ — a fact that has transformed how researchers understand the gut-metabolism relationship.
Short-Chain Fatty Acid Production
When probiotic bacteria ferment prebiotic dietary fibers in the colon, they produce short-chain fatty acids (SCFAs) — primarily acetate, propionate, and butyrate. These small molecules act as critical metabolic signals throughout the body. Acetate reaches the liver and peripheral tissues, where it participates in fatty acid and cholesterol synthesis regulation. Propionate contributes to hepatic gluconeogenesis control. Butyrate serves as the preferred fuel source for colonocytes and has potent anti-inflammatory and epigenetic effects on metabolic gene expression.[4]
Research demonstrates that higher butyrate levels in the gut are causally associated with improved insulin response following glucose tolerance tests, while impaired propionate metabolism is linked to increased type 2 diabetes risk — suggesting that SCFA production is not merely a marker of gut health but a driver of metabolic outcomes.[8]
GLP-1 Stimulation and Appetite Regulation
One of the most important downstream effects of SCFA production is stimulation of glucagon-like peptide-1 (GLP-1) — an incretin hormone produced by intestinal L cells that has become a major pharmaceutical target for obesity and type 2 diabetes. GLP-1 slows gastric emptying, signals the brain to reduce appetite, stimulates insulin secretion in a glucose-dependent manner, and suppresses the counter-regulatory hormone glucagon.[9]
Research has shown that SCFAs produced by probiotic bacteria — particularly butyrate generated by gut commensals fed by Lactobacillus and Bifidobacterium activity — can meaningfully stimulate GLP-1 release from intestinal L cells, normalizing glucose homeostasis and reducing appetite signaling through natural mechanisms.[10] This gut-based GLP-1 pathway is distinct from pharmaceutical GLP-1 receptor agonists but operates through overlapping physiology.
Reduced Metabolic Inflammation
Chronic low-grade inflammation is a central mechanism linking gut dysbiosis to metabolic dysfunction. When the intestinal barrier is compromised — a condition associated with poor microbiome diversity — bacterial lipopolysaccharides (LPS) can translocate into circulation, triggering inflammatory cascades that directly impair insulin signaling in muscle, liver, and adipose tissue. Probiotic strains with well-documented intestinal barrier-strengthening properties help prevent this endotoxemia and reduce circulating inflammatory markers including TNF-α, IL-6, and C-reactive protein.[5]
Improved Insulin Sensitivity Through AMPK Activation
Several probiotic strains have been shown to activate AMP-activated protein kinase (AMPK) — a master metabolic regulator sometimes called the body's "fuel gauge." AMPK activation increases fatty acid oxidation in the liver, enhances glucose uptake in skeletal muscle, and suppresses inflammatory gene expression. Research specifically implicates upregulation of adiponectin production in adipose tissue as a key mechanism by which certain Lactobacillus strains improve insulin sensitivity via the AMPK pathway.[3]
The Gut Barrier and Metabolic Health
A compromised intestinal barrier is one of the most underappreciated contributors to metabolic dysfunction. Strains like Lactobacillus plantarum, L. rhamnosus, and Bifidobacterium longum have been studied for their roles in strengthening tight junction proteins that maintain barrier integrity — reducing the LPS leakage that drives metabolic endotoxemia. If you're concerned about gut permeability as part of the picture, our guide on probiotics for leaky gut and intestinal barrier repair examines the clinical evidence in detail.
Best Probiotic Strains for Metabolic Health
The following strains are those with the strongest peer-reviewed evidence for metabolic benefits — and every one of them is included in MicroBiome Restore. Only strains in our 26-strain formula are discussed here, and only those with direct metabolic research behind them.
Lactobacillus gasseri: The Visceral Fat Specialist
Lactobacillus gasseri has accumulated the most robust clinical evidence of any probiotic strain specifically for abdominal fat reduction. In a landmark multicenter, double-blind, randomized, placebo-controlled trial of 87 adults with elevated BMI and abdominal visceral fat, subjects consuming fermented milk containing L. gasseri SBT2055 (LG2055) for 12 weeks experienced a statistically significant 4.6% decrease in abdominal visceral fat area from baseline — with subcutaneous fat also significantly reduced — compared to the control group. Body weight, waist circumference, hip circumference, and BMI also decreased meaningfully in the probiotic group.[1]
A separate randomized, double-blind, placebo-controlled trial with L. gasseri BNR17 in 90 overweight adults confirmed that the high-dose group (1010 CFU/day) achieved a statistically significant reduction in visceral adipose tissue compared to placebo, with improvements in body weight and waist circumference also observed.[11] Mechanistically, L. gasseri appears to reduce adiposity by upregulating fatty acid oxidation genes (including PPARα and CPT1) and suppressing fat synthesis gene expression (SREBP-1c, ACC), effectively shifting the liver's metabolic balance toward burning rather than storing fat.
For a detailed look at dosing protocols used in L. gasseri trials and what that means for supplementation, see our Lactobacillus gasseri dosage guide for weight loss.
Bifidobacterium breve: Body Fat Reduction in Humans
Bifidobacterium breve B-3 has been evaluated in multiple human randomized controlled trials specifically for body fat outcomes. In an 80-participant, double-blind, placebo-controlled trial in pre-obese adults (BMI 25–30), those receiving B. breve B-3 for 12 weeks showed significantly lower body fat mass and percent body fat compared to the placebo group at weeks 8 and 12. Visceral fat area increased in the placebo group over the same period but remained stable in the B-3 group. Triglyceride levels also showed a modest downward trend in the treated group.[2]
A follow-up randomized clinical trial confirmed body fat reduction, waist circumference reduction, and hip circumference reduction in overweight participants receiving the strain for 12 weeks, with researchers concluding that the strain can safely and effectively reduce body fat and related anthropometric measures.[12] The proposed mechanism involves upregulation of glucagon-like peptide expression in the intestine and adiponectin expression in adipose tissue — both metabolically favorable hormonal changes.
Lactobacillus rhamnosus: Insulin Sensitivity and Metabolic Regulation
Lactobacillus rhamnosus is one of the most extensively studied probiotic species in the context of metabolic health. Research has shown that L. rhamnosus GG (LGG) improves insulin sensitivity in high-fat-diet conditions through a mechanism involving enhanced adiponectin production in adipose tissue, which in turn activates AMPK in both skeletal muscle and liver — increasing fatty acid oxidation and reducing hepatic fat accumulation.[3]
In human research, L. rhamnosus HA-114 supplementation over 12 weeks reduced plasma insulin levels, HOMA-IR (a measure of insulin resistance), LDL cholesterol, and triglycerides, and was additionally associated with improvements in eating behaviors including reduced binge eating and food cravings.[13] This strain also modulates the gut microbiota to decrease LPS-producing bacteria while increasing SCFA-producing commensals — addressing metabolic endotoxemia at its microbial source. For context on how L. rhamnosus fits the broader landscape of beneficial Lactobacillus species, see our Lactobacillus rhamnosus benefits guide.
Bacillus coagulans: Blood Sugar and Inflammation Control
Unlike most probiotic species, Bacillus coagulans forms heat-stable spores that survive gastric transit reliably — making it uniquely suited to deliver consistent metabolic benefits. A randomized, double-blind, placebo-controlled clinical trial in 50 patients with type 2 diabetes found that a synbiotic containing B. coagulans plus L. rhamnosus and L. acidophilus significantly reduced fasting blood glucose, insulin, and HOMA-IR, as well as high-sensitivity CRP (a key inflammatory marker), compared to placebo after 12 weeks.[5]
A separate randomized, placebo-controlled clinical trial in patients with non-alcoholic fatty liver disease (NAFLD) — a condition driven by metabolic dysfunction — found that B. coagulans GBI-30 supplementation significantly reduced hepatic steatosis, liver enzymes, and TNF-α and NF-κB activity, supporting its role in the metabolic inflammation pathway.[14] For more on B. coagulans and its documented clinical applications, see our Bacillus coagulans benefits article.
Lactobacillus plantarum: SCFA Production and Lipid Metabolism
Lactobacillus plantarum is a robust colonizer of the human colon and one of the most studied probiotic species for SCFA production. Research shows that L. plantarum consistently increases acetate, propionate, and butyrate production in human gut models — stimulating key metabolic signaling cascades that regulate energy homeostasis, reduce lipid accumulation, and improve gut barrier integrity.[15] Animal studies have demonstrated that L. plantarum strains regulate lipid metabolism by modulating the AMPK pathway and downregulating the lipogenesis-related proteins PPARγ, LXR-α, and SREBP-1C. You can explore the full Lactobacillus plantarum health benefits covered in our dedicated guide.
Lactobacillus paracasei: Cholesterol and Lipid Support
Lactobacillus paracasei has been identified as a significant contributor to SCFA production in the gut, particularly propionate — which plays a direct role in hepatic cholesterol synthesis regulation and insulin signaling. In combination studies, L. paracasei worked synergistically with other Lactobacillus species to significantly inhibit weight gain, improve glucose tolerance, and reduce serum lipid levels in high-fat diet models.[6]
| Strain | Primary Metabolic Benefit | Key Evidence |
|---|---|---|
| L. gasseri | Visceral fat reduction, body weight | 4.6% visceral fat decrease (multicenter RCT)[1] |
| B. breve | Body fat reduction, body composition | Significant fat reduction vs. placebo (RCT)[2] |
| L. rhamnosus | Insulin sensitivity, lipid profile | Reduced HOMA-IR, LDL, triglycerides (human trial)[13] |
| B. coagulans | Blood glucose, inflammation | Significant reductions in FBG, insulin, CRP (RCT)[5] |
| L. plantarum | SCFA production, lipid metabolism | Increased propionate and butyrate; lipogenesis inhibition[15] |
| L. paracasei | Cholesterol regulation, metabolic balance | Synergistic weight and lipid effects (multi-strain study)[6] |
| L. acidophilus | Gut barrier integrity, microbiome modulation | Increased butyrate; beneficial microbiota shift[15] |
All Seven Strains Above — Plus 19 More — in One Filler-Free Capsule
MicroBiome Restore delivers 26 clinically studied probiotic strains at 15 billion CFU per serving, with 9 organic prebiotics to fuel them. No microcrystalline cellulose. No magnesium stearate. No titanium dioxide.
Why Multi-Strain Formulas Matter for Metabolic Health
When researchers compare single-strain versus multi-strain probiotic interventions for metabolic outcomes, the multi-strain formulas consistently perform better. A study examining the combined effects of L. plantarum, L. paracasei, and L. rhamnosus GG found that the multi-strain combination showed a more pronounced anti-adipogenic effect in pre-adipocyte cells than any individual strain in isolation. The combination also more effectively inhibited weight gain, improved glucose tolerance, improved insulin sensitivity, and reduced serum lipid levels in an obese mouse model across both an 8-week and a 12-week intervention.[6]
The reason is structural: different strains colonize different segments of the intestinal tract, ferment different substrates, and produce different metabolic byproducts. A Lactobacillus species that excels at producing acetate in the proximal colon may depend on a complementary Bifidobacterium species to maintain the pH conditions that allow its colonization. Bacillus spore-formers survive gastric acid and establish early colonization, creating a more hospitable environment for more acid-sensitive strains that follow. These interactions are synergistic — each strain amplifying the effect of the others.
A systematic review and meta-analysis of 21 randomized controlled trials found that Bifidobacteria supplementation was effective in weight management for overweight or obese individuals, with the treatment group showing a statistically significant decrease in weight and BMI compared to controls — reinforcing the case for Bifidobacterium as a core component of any metabolically oriented probiotic formula.[16]
If you're evaluating single-strain versus multi-strain options, our detailed comparison on single vs. multi-strain probiotics covers the tradeoffs in depth.
The Soil-Based Advantage for Metabolic Support
MicroBiome Restore includes six Bacillus species — B. coagulans, B. subtilis, B. clausii, B. licheniformis, B. pumilus, and B. licheniformis — that form endospores capable of surviving gastric acid and reaching the intestine viable and active. Research on Bacillus subtilis specifically has shown that it produces a range of antimicrobial compounds that help suppress pathogenic bacteria competing for gut real estate, creating space for beneficial Lactobacillus and Bifidobacterium species to establish themselves — enhancing the metabolic impact of the whole formula. You can explore the evidence on Bacillus subtilis probiotic benefits in our dedicated article.
Prebiotics, SCFAs, and Metabolic Signaling
Probiotics without prebiotic support are like seeds without soil. The metabolic benefits of Lactobacillus and Bifidobacterium strains depend in large part on their ability to ferment dietary fibers into the SCFAs that act as metabolic signals throughout the body. Without adequate prebiotic substrate, probiotic strains produce fewer of these critical metabolites — limiting the depth of their metabolic impact.
This is particularly relevant for the SCFA-to-GLP-1 pathway. Research has demonstrated that acetate produced by gut bacteria directly stimulates GLP-1 release by intestinal L cells, connecting prebiotic fiber intake → probiotic fermentation → SCFA production → GLP-1 secretion → improved appetite regulation and glucose homeostasis in a single mechanistic chain.[10]
MicroBiome Restore includes nine organic prebiotics chosen to support this pathway without introducing prebiotic fibers not found in our formula. Jerusalem artichoke is among the richest natural sources of inulin-type fructooligosaccharides (FOS), which are selectively fermented by Bifidobacterium and Lactobacillus species to produce propionate and butyrate. You can read more about the specific research on Jerusalem artichoke and inulin for probiotic growth.
Acacia fiber (from Acacia senegal) is a soluble fiber that has been clinically studied for its particularly gentle fermentation profile and its ability to selectively promote Bifidobacterium and Lactobacillus populations even in sensitive digestive systems — making it especially valuable for those whose gut microbiomes are in a disrupted state. Our article on acacia fiber for sensitive guts examines this research in detail. The formula also includes maitake mushroom, bladderwrack, Norwegian kelp, oarweed, and fig fruit — each contributing unique prebiotic polysaccharides that feed different communities of beneficial bacteria and diversify SCFA output.
A Note on What "Boosting Metabolism" Actually Means
Probiotics are not thermogenic stimulants. They don't work like caffeine or ephedrine. The metabolic improvements documented in clinical research reflect changes in how efficiently the body processes calories, stores fat, manages blood sugar, and responds to hormonal signals — not acute increases in energy expenditure. The mechanisms are real and clinically meaningful, but they operate over weeks to months through gut microbiome modulation. Managing expectations around timeline is essential: most probiotic trials showing metabolic effects used 12-week intervention periods.
What to Look for in a Metabolism-Supporting Probiotic
Most commercial probiotics are formulated for shelf stability and manufacturing convenience — not clinical efficacy. If the goal is meaningful metabolic support, several formulation factors deserve close attention beyond the brand name on the label.
Strain Specificity, Not Just CFU Count
Colony-forming unit (CFU) count is the number most prominently advertised on probiotic packaging, but it's far from the most important variable. A product with 50 billion CFU of a single, poorly chosen strain will underperform a well-formulated 15 billion CFU multi-strain product every time. The research reviewed in this article specifies strains — not just genera. Look for labels that identify bacteria to the strain level (e.g., Lactobacillus gasseri SBT2055 or BNR17), not just the species level.
Capsule Technology and Survivability
Stomach acid is hostile to most probiotic bacteria. Products that don't use acid-resistant capsule technology may deliver far fewer viable bacteria to the small intestine than their CFU count suggests. Pullulan capsules — the delivery format used in MicroBiome Restore — are made from fermented tapioca and provide a natural delayed-release mechanism. They're also prebiotic themselves, breaking down in the gut to feed beneficial bacteria rather than dissolving immediately in the stomach.
The contrast with hypromellose (HPMC) capsules is worth understanding if you're comparing products. Our article on pullulan versus HPMC capsules for gut health covers what the research says about each.
Clean Formulation: The Filler Problem
Conventional probiotic supplements routinely contain inactive ingredients that can undermine gut health — ironically counteracting the product's stated purpose. Microcrystalline cellulose (MCC), one of the most common fillers in the supplement industry, has been associated with gut microbiome disruption in some research. Magnesium stearate, another ubiquitous flow agent, may interfere with bacterial viability and absorption. Titanium dioxide — used as a whitening agent — has raised safety flags in emerging research.
Learning to read probiotic supplement labels for hidden fillers is one of the most useful skills you can develop when evaluating any gut health product. The "other ingredients" section tells the real story.
Prebiotic Inclusion
As discussed, the metabolic benefits of probiotic bacteria depend in large part on their ability to ferment prebiotic fiber into SCFAs. A probiotic formula that doesn't include prebiotics leaves the bacterial strains dependent on whatever fiber happens to be present in the gut at that moment — an unreliable foundation for consistent metabolic effects. The most effective metabolic probiotic products include both populations of beneficial bacteria and the substrates needed to fuel their metabolic activity.
Formulated for Metabolic Depth, Not Just Label Appeal
MicroBiome Restore combines 26 probiotic strains — including every metabolically active strain discussed in this article — with 9 organic prebiotics and 80+ trace minerals, in a filler-free pullulan capsule. No flow agents. No synthetic binders. Just the ingredients your gut actually needs.
Frequently Asked Questions
Do probiotics actually speed up metabolism?
The more precise framing is that specific probiotic strains can improve metabolic efficiency — meaning the body processes nutrients, regulates blood sugar, and manages fat storage more effectively. Clinical trials have documented reductions in visceral fat, improvements in insulin sensitivity, and reductions in blood lipids in probiotic-treated groups. However, the effect is not a thermogenic stimulant effect and should not be expected to produce rapid, dramatic weight loss. The metabolic improvements are real but modest and cumulative over a 12-week or longer intervention period.
Which probiotic is best for belly fat specifically?
Lactobacillus gasseri has the most direct human clinical evidence for visceral fat reduction — the fat stored around abdominal organs that correlates most strongly with metabolic disease risk. Multiple randomized controlled trials have documented statistically significant reductions in visceral adipose tissue area with L. gasseri supplementation compared to placebo. That said, the broader metabolic environment — including diverse Bifidobacterium populations, adequate SCFA production, and reduced systemic inflammation — collectively matters more than any single strain.
How long do probiotics take to affect metabolism?
Most clinical trials documenting metabolic outcomes used 12-week intervention periods. Some studies have observed early improvements in digestive function and inflammatory markers within 4–8 weeks, while body composition changes typically require the full 12-week period to reach statistical significance. Consistent daily supplementation throughout this window is critical — probiotic colonization is transient, and the metabolic benefits depend on maintaining active bacterial populations over time.
Can probiotics help with insulin resistance?
Yes — this is one of the best-supported metabolic applications of probiotic supplementation. Multiple randomized controlled trials across different strains and populations have documented improvements in HOMA-IR (a validated measure of insulin resistance), fasting insulin, and fasting blood glucose. The mechanisms are well characterized: reduced metabolic endotoxemia, increased adiponectin production, AMPK pathway activation in skeletal muscle and liver, and GLP-1 stimulation through SCFA production all contribute to improved insulin sensitivity through distinct but complementary pathways. For those managing blood sugar, our article on probiotics for type 2 diabetes and blood sugar examines the clinical evidence specifically for that population.
Should I take a probiotic with or without food for metabolic benefits?
Most research on probiotic supplementation for metabolic outcomes does not specify a strict timing protocol relative to meals. However, taking probiotics with or shortly after a meal provides some protection against stomach acid degradation — food buffers gastric pH and may improve bacterial survivability before reaching the small intestine. For formulas using pullulan capsules (like MicroBiome Restore), the capsule material itself provides acid-protection, making timing somewhat less critical, though consistency of dosing daily is far more important than the specific meal-timing window.
The Bottom Line on Probiotics and Metabolic Health
The science connecting gut microbiome composition to metabolic health has moved from hypothesis to well-established mechanism. Specific probiotic strains — particularly Lactobacillus gasseri, Bifidobacterium breve, Lactobacillus rhamnosus, Bacillus coagulans, and Lactobacillus plantarum — have documented metabolic effects including visceral fat reduction, improved insulin sensitivity, reduced systemic inflammation, and better blood lipid profiles, confirmed in peer-reviewed randomized controlled trials.
These effects are real, but they are also nuanced. They require the right strains at meaningful doses, delivered in a format that survives to the gut, supported by prebiotic fiber that allows those strains to produce the SCFAs that drive metabolic signaling. A single-strain product with synthetic fillers and no prebiotic support represents a fundamentally different intervention than a multi-strain, filler-free formula with integrated prebiotic support — even if both are labeled "probiotic."
For a comprehensive look at what makes MicroBiome Restore different from standard probiotic products, our complete guide to MicroBiome Restore walks through every ingredient and its clinical rationale. The gut-metabolism connection is real — the question is whether your probiotic is formulated to actually leverage it.
References
- Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., ... & Tsuchida, T. (2010). Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition, 64(6), 636–643. https://doi.org/10.1038/ejcn.2010.19
- Minami, J., Kondo, S., Yanagisawa, N., Odamaki, T., Xiao, J. Z., Abe, F., ... & Shimoda, T. (2015). Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial. Journal of Nutritional Science, 4, e23. https://doi.org/10.1017/jns.2015.7
- Kim, S. W., Park, K. Y., Kim, B., Kim, E., & Hyun, C. K. (2013). Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochemical and Biophysical Research Communications, 431(2), 258–263. https://doi.org/10.1016/j.bbrc.2012.12.121
- Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015). Short-chain fatty acids in control of body weight and insulin sensitivity. Nature Reviews Endocrinology, 11(10), 577–591. https://doi.org/10.1038/nrendo.2015.128
- Hassanzadeh Haghighi, M., & Ghafouri-Fard, S. (2021). Does symbiotic supplementation which contains Bacillus coagulans, Lactobacillus rhamnosus, Lactobacillus acidophilus and fructooligosaccharide have favourite effects in patients with type-2 diabetes? A randomised, double-blind, placebo-controlled trial. Archives of Physiology and Biochemistry, 127(5), 441–446. https://doi.org/10.1080/13813455.2021.1931925
- Yin, M., Sun, W., Zhou, Q., Wang, Y., & He, H. (2025). Supplementation of mixed Lactobacillus alleviates metabolic impairment, inflammation, and dysbiosis of the gut microbiota in an obese mouse model. Frontiers in Nutrition, 12, 1554996. https://doi.org/10.3389/fnut.2025.1554996
- Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., ... & Gordon, J. I. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences, 101(44), 15718–15723. https://doi.org/10.1073/pnas.0407076101
- Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vila, A. V., Võsa, U., ... & McCarthy, M. I. (2019). Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nature Genetics, 51(4), 600–605. https://doi.org/10.1038/s41588-019-0350-x
- Zeng, Y., Li, S., Liu, C., Guo, T., Hu, X., Feng, F., & Zhang, H. (2024). Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. mBio, 15(1), e02032-23. https://doi.org/10.1128/mbio.02032-23
- Yadav, H., Lee, J. H., Lloyd, J., Walter, P., & Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry, 288(35), 25088–25097. https://doi.org/10.1074/jbc.M113.452516
- Kang, J. H., Yun, S. I., Park, M. H., Park, J. H., Jeong, S. Y., & Park, H. O. (2019). Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: a randomized, double-blind, placebo-controlled trial. Journal of Medicinal Food, 22(9), 881–888. https://doi.org/10.1089/jmf.2017.3937
- Sung, H. K., Kim, Y. Y., Youn, S. J., Choi, Y., & Eun, S. W. (2023). Body fat reduction effect of Bifidobacterium breve B-3: a randomized, double-blind, placebo comparative clinical trial. Nutrients, 15(1), 28. https://doi.org/10.3390/nu15010028
- Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., ... & Tremblay, A. (2014). Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition, 111(8), 1507–1519. https://doi.org/10.1017/S0007114513003875
- Abhari, K., Saadati, S., Yari, Z., Hosseini, H., Hedayati, M., Abhari, S., ... & Hekmatdoost, A. (2020). The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, clinical trial. Journal of Functional Foods, 74, 104198. https://doi.org/10.1016/j.jff.2020.104198
- Bagheri, N., & Rad, A. H. (2020). The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients, 12(4), 1107. https://doi.org/10.3390/nu12041107
- Lin, Y., Zheng, W., Zheng, K., Lin, X., & Pan, Z. (2024). Effects of Bifidobacterium on metabolic parameters in overweight or obesity adults: a systematic review and meta-analysis. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1354623
'%3e%3cg%20id='Final-Copy-2_2_'%20transform='translate(1275.000000,%20200.000000)'%3e%3cpath%20class='st0'%20d='M7.4,12.8h6.8l3.1-11.6H7.4C4.2,1.2,1.6,3.8,1.6,7S4.2,12.8,7.4,12.8z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3cg%20id='final---dec.11-2020'%3e%3cg%20id='_x30_208-our-toggle'%20transform='translate(-1275.000000,%20-200.000000)'%3e%3cg%20id='Final-Copy-2'%20transform='translate(1275.000000,%20200.000000)'%3e%3cpath%20class='st1'%20d='M22.6,0H7.4c-3.9,0-7,3.1-7,7s3.1,7,7,7h15.2c3.9,0,7-3.1,7-7S26.4,0,22.6,0z%20M1.6,7c0-3.2,2.6-5.8,5.8-5.8%20h9.9l-3.1,11.6H7.4C4.2,12.8,1.6,10.2,1.6,7z'/%3e%3cpath%20id='x'%20class='st2'%20d='M24.6,4c0.2,0.2,0.2,0.6,0,0.8l0,0L22.5,7l2.2,2.2c0.2,0.2,0.2,0.6,0,0.8c-0.2,0.2-0.6,0.2-0.8,0%20l0,0l-2.2-2.2L19.5,10c-0.2,0.2-0.6,0.2-0.8,0c-0.2-0.2-0.2-0.6,0-0.8l0,0L20.8,7l-2.2-2.2c-0.2-0.2-0.2-0.6,0-0.8%20c0.2-0.2,0.6-0.2,0.8,0l0,0l2.2,2.2L23.8,4C24,3.8,24.4,3.8,24.6,4z'/%3e%3cpath%20id='y'%20class='st3'%20d='M12.7,4.1c0.2,0.2,0.3,0.6,0.1,0.8l0,0L8.6,9.8C8.5,9.9,8.4,10,8.3,10c-0.2,0.1-0.5,0.1-0.7-0.1l0,0%20L5.4,7.7c-0.2-0.2-0.2-0.6,0-0.8c0.2-0.2,0.6-0.2,0.8,0l0,0L8,8.6l3.8-4.5C12,3.9,12.4,3.9,12.7,4.1z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Your Privacy Choices
Share and get 15% off!
Simply share this product on one of the following social networks and you will unlock 15% off!